Peptide record

TPDB09672

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09672
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GILSTVFKAGKGIVCGLSGLC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H155N23O25S2
RNDEQHMPWY
G
2023.48
9.11
2
0
9
+2
-1.16
1.252
125.24
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.06
5
Residue Composition
number
1
A
0
R
0
N
0
D
2
C
0
E
0
Q
5
G
0
H
2
I
3
L
2
K
0
M
1
F
0
P
2
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 5 H: 0 I: 2 L: 3 K: 2 M: 0 F: 1 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
21 reviewed residue count
C90H155N23O25S2 sequence-only estimate (linear, free termini)
2023.48 sequence-only estimate (linear, free termini)
9.11 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-1.16 sequence-only estimate (linear, free termini)
1.252 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 u
Evidence 2 Activity

Activity

MIC
Antibacterial
3.1-25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
12.5 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 4 Activity

Activity

MIC
Antibacterial
100 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

st E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 5 Activity

Activity

MIC
Antifungal
50 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 u
Evidence 6 Activity

Activity

MIC
Antifungal
3.1-25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 7 Activity

Activity

MIC
Antifungal
12.5 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 8 Activity

Activity

MIC
Antifungal
100 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

st E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 9 Activity

Activity

MIC
Antiparasitic
50 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 u
Evidence 10 Activity

Activity

MIC
Antiparasitic
3.1-25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 11 Activity

Activity

MIC
Antiparasitic
12.5 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 12 Activity

Activity

MIC
Antiparasitic
100 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

st E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 13 Activity

Activity

MIC
Antiviral
50 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 u
Evidence 14 Activity

Activity

MIC
Antiviral
3.1-25 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 15 Activity

Activity

MIC
Antiviral
12.5 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

Active against E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).
Evidence 16 Activity

Activity

MIC
Antiviral
100 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

st E. coli (MIC 50 uM), S. aureus or MRSA (MIC 3.1-25 uM), B. subtilis (MIC 12.5 uM), and C. albicans (MIC 100 uM).